Kura Oncology Inc. (KURA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Kura Oncology Inc.

NASDAQ: KURA · Real-Time Price · USD
9.05
0.69 (8.25%)
At close: Sep 26, 2025, 3:59 PM
9.12
0.77%
After-hours: Sep 26, 2025, 07:26 PM EDT

Kura Oncology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
224.46M 37.32M 51.8M 90.67M
Short-Term Investments
502.93M 386.64M 386.18M 427.29M
Long-Term Investments
n/a n/a 210K 210K
Other Long-Term Assets
7.84M 7.6M 3.29M 3.31M
Receivables
6.1M 2.8M n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
11.33M 5.72M 8.44M 1.4M
Total Current Assets
744.83M 432.48M 446.43M 522.29M
Property-Plant & Equipment
7.49M 8.85M 6.38M 8.25M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
15.33M 16.45M 9.88M 11.76M
Total Assets
760.16M 448.94M 456.31M 534.05M
Account Payables
1.47M 2.3M 1.53M 3.24M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
4.49M n/a n/a 2.26M
Other Current Liabilities
68.81M 13.15M 10.3M -2.26M
Total Current Liabilities
78.71M 35.26M 24.06M 22.45M
Long-Term Debt
6.92M 9.33M 9.16M n/a
Other Long-Term Liabilities
1.79M 705K 265K 375K
Total Long-Term Liabilities
267.81M 16.4M 11.97M 4.99M
Total Liabilities
346.52M 51.66M 36.03M 27.44M
Total Debt
16.59M 17.2M 14.02M 6.88M
Book Value
413.64M 397.27M 420.28M 506.61M
Book Value Per Share
4.80 5.43 6.27 7.64
Common Stock
8K 7K 7K 7K
Retained Earnings
-895.42M -721.44M -568.81M -432.97M
Comprehensive Income
764K -1.27M -8.03M -1.79M
Shareholders Equity
413.64M 397.27M 420.28M 506.61M
Total Investments
502.93M 386.64M 386.18M 427.29M